These findings further indicate that the onset of AD seems to be related with alterations in Cx43 phosphorylation, whereas advanced AD stages involve alterations in Cx43 levels, which is consistent with the progressive increase in Cx43 levels observed in APP/PS1 and 5xFAD mice [59] as well as in AD patients [55]. The gene discussed is APP; the disease is Alzheimer disease.